Excretion of epidermal growth factor in human adult polycystic kidney disease.
In chronic renal failure, epidermal growth factor (EGF) excretion is decreased. In this study, asymptomatic adult polycystic kidney disease (APKD) patients with a relatively preserved glomerular filtration rate were examined. Excretion of EGF was studied in 6 patients with APKD (median age 42 years; serum creatinine [median] 95 [range-80-133] mumol/l) and compared with that of 28 healthy controls. EGF was determined in a spot morning urine by using a specific radioimmunoassay, and expressed in relation to creatinine excretion. Excretion of EGF in APKD was (median) 157 (range-13-359) and in the controls (median) 546 (range-238-1199) pmol/mmol creatinine (p < 0.001). Low excretion of EGF in APKD patients with preserved kidney function suggests a distal abnormality at an early stage of the disease, prior to the development of renal failure.
Weinstein
T
T
Department of Nephrology, Rabin Medical Center-Golda (Hasharon) Campus, Petah-Tikva.
Hwang
D
D
Lev-Ran
A
A
Ori
Y
Y
Korzets
A
A
Levi
J
J
D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003404:Creatinine / Q000652:urine; D004815:Epidermal Growth Factor / Q000502:physiology / Q000652:urine*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D007686:Kidney Tubules, Distal / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D007690:Polycystic Kidney Diseases / Q000150:complications / Q000503:physiopathology / Q000652:urine*; D011863:Radioimmunoassay
D004815:Epidermal Growth Factor; D003404:Creatinine